ArticleMetabolites2022

Metabolomic Signatures in Doxorubicin-Induced Metabolites Characterization, Metabolic Inhibition, and Signaling Pathway Mechanisms in Colon Cancer HCT116 Cells.

Raja Ganesan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.